# Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

> **NCT05934799** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 60 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Clopidogrel film-coated tablet 75 mg
- **DRUG:** Plavix® film-coated tablet 75 mg

## Key facts

- **NCT ID:** NCT05934799
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-16
- **Primary completion:** 2023-07-23
- **Final completion:** 2023-10-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05934799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05934799, "Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05934799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*